Mr. Rob van Santen reports

VALENS GROWORKS UPSIZES PRIVATE PLACEMENT

Valens Groworks Corp. has increased its previously announced private placement to an offering of two million units of the company at a price of $1 per unit for gross proceeds of up to $2-million. Following the previously announced closed tranches totalling $712,700, this increase will accommodate an additional $1,287,300 as a potential final tranche. The corporation intends to use the net proceeds from the offering to advance the operations at its 17,000-square-foot facility in Kelowna and complete its initial cannabis crop. Remaining proceeds, if any, will be used for general corporate purposes.

Each unit consists of one common share of the company and one-half of a common share purchase warrant. Each warrant will entitle the holder thereof to purchase one common share at a price of $1.50 for a period of 12 months from the closing of the offering, subject to the acceleration provision described herein. The units are being made available by way of prospectus exemptions in Canada and in such other jurisdictions as the company may agree where the units can be issued on a private placement basis, exempt from any prospectus, registration or other similar requirements.

The company will be entitled to accelerate the expiry date of the warrants to the date that is 30 days following the date the company issues a news release announcing that the published closing price of the common shares on the Canadian Securities Exchange has been equal to or greater than $2 for 10 consecutive trading days after the hold period on the common shares has expired.

Closing of the offering is subject to regulatory approval, including that of the CSE. The company may pay a finder's fee on the non-insider portion of the offering within the amount permitted by the policies of the CSE. All securities issued in connection with the offering will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation.

About Valens Groworks Corp.

Valens Groworks is Canadian publicly traded biotechnology company executing on its plant-to-premium-product objectives through two wholly owned subsidiaries, located at the company's expanding 17,000-square-foot facility on two acres in Kelowna in the heart of British Columbia's Okanagan Valley. Subsidiary Valens Agritech is commencing cannabis production and sales under a Health Canada dealer licence and is also a late-stage licence applicant to cultivate medical marijuana under the ACMPR (Access to Cannabis for Medical Purposes Regulations) for individual patients. Subsidiary Supra THC Services is a Health Canada-licensed cannabis testing lab providing sector-leading analytical and proprietary services to licensed producers, ACMPR patients and the natural health products industry.

We seek Safe Harbor.